Allreal continued to be extremely successful in the first half-year of 2010. Total sales grew by 13.2% to CHF 306.6 million. Net profit of CHF 62.3 million clearly exceeded the previous year’s value of CHF 39.4 million. The highest half-year result ever attained by Allreal underlines the company’s performance as well as its very good positioning in a demanding market environment. Link: Click Here

Nestlé yesterday completed the sale of its remaining shares in Alcon to Novartis, representing around 52% of Alcon's share capital, for USD 28.3 billion. Nestlé acquired Alcon in 1977 for USD 280 million. Over the years, Nestlé supported Alcon's R&D drive and international expansion, enabling the company to build a significant global leadership position in the eye care business. Link: Click Here

Novartis announced today that it has completed its purchase of Alcon stock from Nestlé resulting in 77% ownership of Alcon. This has been achieved by completing the acquisition of the remaining 52% of Alcon shares owned by Nestlé for a total of USD 28.3 billion. Link: Click Here